Neurosigma Inc - Product Pipeline Analysis, 2019 Update
November 2019
42
About the Report
About the Report
Summary
Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. It offers Monarch eTNS System for treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD). The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stress disorders. It also conducts preclinical research and development, and phase clinical trials. The company trigeminal nerve stimulation has been investigated as a therapy for epilepsy, depression, attention deficity hyperactivity disorder, and post-traumatic stress disorder, Lennox-Gastaut syndrome and traumatic brain injuries, among others. NeuroSigma is headquartered in Los Angeles, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Neurosigma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Neurosigma Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
NeuroMEDx
InnovaQuartz LLC
CJPS Medical Systems, LLC
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Neurosigma Inc Company Overview
Neurosigma Inc Company Snapshot
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc-Pipeline Analysis Overview
Neurosigma Inc-Key Facts
Neurosigma Inc-Major Products and Services
Neurosigma Inc Pipeline Products by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Pipeline Products Overview
Deep Brain Stimulation System-Cachexia
Deep Brain Stimulation System-Cachexia Product Overview
Deep Brain Stimulation System-Obesity
Deep Brain Stimulation System-Obesity Product Overview
DELTA Stent
DELTA Stent Product Overview
Flow-Diverting TFN Stent
Flow-Diverting TFN Stent Product Overview
Micropatterned TFN Stent
Micropatterned TFN Stent Product Overview
Monarch eTNS System-Depression
Monarch eTNS System-Depression Product Overview
Monarch eTNS System-Depression Clinical Trial
Monarch eTNS System-Epilepsy
Monarch eTNS System-Epilepsy Product Overview
Monarch eTNS System-Epilepsy Clinical Trial
Monarch eTNS System-Lennox-Gastaut Syndrome
Monarch eTNS System-Lennox-Gastaut Syndrome Product Overview
Monarch eTNS System-Post-Traumatic Stress Disorder
Monarch eTNS System-Post-Traumatic Stress Disorder Product Overview
Monarch eTNS System-Traumatic Brain Injury
Monarch eTNS System-Traumatic Brain Injury Product Overview
sTNS System-Epilepsy
sTNS System-Epilepsy Product Overview
Thin Film Nitinol Flow Diverting Stent
Thin Film Nitinol Flow Diverting Stent Product Overview
Neurosigma Inc-Key Competitors
Neurosigma Inc-Key Employees
Neurosigma Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Neurosigma Inc, Recent Developments
Oct 08, 2019: NeuroSigma announces partnership with Quick Care Pharmacy for sales and distribution of the Monarch eTNS System in the US
Jun 27, 2019: NeuroSigma announces presentation of clinical trial data showing increased brain activity and improved cognition in children with ADHD Treated with eTNS
May 01, 2019: CCHR condemns FDA's approval of Electricity-Zapping for 'ADHD' kids
Apr 23, 2019: NeuroSigma announces FDA clearance of Monarch eTNS System as first non-drug treatment for pediatric ADHD
Apr 23, 2019: FDA clears NeuroSigma's Monarch device to treat ADHD
Oct 30, 2017: UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD
Jan 28, 2016: Electric patch holds promise for treating PTSD
Dec 10, 2015: Preliminary Results Utilizing NeuroSigma's Monarch eTNS System for the Treatment of Traumatic Brain Injury Presented at the North American Neuromodulation Society Annual Meeting
Nov 16, 2015: NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD
May 04, 2015: NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Neurosigma Inc Pipeline Products by Equipment Type
Neurosigma Inc Pipeline Products by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc Pipeline Products by Equipment Type
Neurosigma Inc Pipeline Products by Indication
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc, Key Facts
Neurosigma Inc, Major Products and Services
Neurosigma Inc Number of Pipeline Products by Development Stage
Neurosigma Inc Pipeline Products Summary by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Ongoing Clinical Trials Summary
Deep Brain Stimulation System-Cachexia-Product Status
Deep Brain Stimulation System-Cachexia-Product Description
Deep Brain Stimulation System-Obesity-Product Status
Deep Brain Stimulation System-Obesity-Product Description
DELTA Stent-Product Status
DELTA Stent-Product Description
Flow-Diverting TFN Stent-Product Status
Flow-Diverting TFN Stent-Product Description
Micropatterned TFN Stent-Product Status
Micropatterned TFN Stent-Product Description
Monarch eTNS System-Depression-Product Status
Monarch eTNS System-Depression-Product Description
Monarch eTNS System-Depression-Effect of TNS for Major Depressive Disorder in the Elderly: A Phase II Randomized Controlled Trial
Monarch eTNS System-Depression-External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Depression
Monarch eTNS System-Depression-Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: A Phase II, Randomized, Double-blind Clinical Trial
Monarch eTNS System-Epilepsy-Product Status
Monarch eTNS System-Epilepsy-Product Description
Monarch eTNS System-Epilepsy-Evaluation of the Monarch eTNS Therapy for Neurological and Neuropsychiatric Disorders in Pediatrics
Monarch eTNS System-Epilepsy-External Trigeminal Nerve Stimulation for Epilepsy
Monarch eTNS System-Lennox-Gastaut Syndrome-Product Status
Monarch eTNS System-Lennox-Gastaut Syndrome-Product Description
Monarch eTNS System-Post-Traumatic Stress Disorder-Product Status
Monarch eTNS System-Post-Traumatic Stress Disorder-Product Description
Monarch eTNS System-Traumatic Brain Injury-Product Status
Monarch eTNS System-Traumatic Brain Injury-Product Description
sTNS System-Epilepsy-Product Status
sTNS System-Epilepsy-Product Description
Thin Film Nitinol Flow Diverting Stent-Product Status
Thin Film Nitinol Flow Diverting Stent-Product Description
Neurosigma Inc, Key Employees
Neurosigma Inc, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.